Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients - 10/07/23
Doi : 10.1016/j.jinf.2023.03.026
Deze Zhao 1
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, China
Furong Laboratory, Changsha, Hunan 410008, China
Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
Yi He 1, Yating Dian, Yu Meng
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, China
Furong Laboratory, Changsha, Hunan 410008, China
Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
Furong Zeng ⁎ 
Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
∗Correspondence to: Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.Department of Oncology, Xiangya Hospital, Central South UniversityChangshaHunanChina
Guangtong Deng ⁎
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, China
Furong Laboratory, Changsha, Hunan 410008, China
Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
∗Correspondence to: Department of Dermatology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan 410008, China.Department of Dermatology, Xiangya Hospital, Central South University87 Xiangya RoadChangshaHunan410008China
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | Elevated troponin levels are one of the common phenomena in COVID-19 patients. |
• | COVID-19 patients with elevated troponin have limited benefit from Paxlovid monotherapy. |
• | Cardiac troponin levels should be closely monitored in patients treated with Paxlovid. |
Plan
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 2
P. 148-150 - août 2023 Retour au numéro
Article précédent
- Nasopharyngeal swabs as alternative specimens for the diagnosis of dengue virus infection
- Alícia Cavalcante Maia, Tatyane de Souza Cardoso Quintão, Pâmela Maria de Oliveira, Évelin Mota Cassemiro, Daiani Cristina Cilião-Alves, Priscilla Pedrette de Melo Alves, Fabiano dos Anjos Pereira Martins, Emerson Luiz Lima Araújo, Helen da Costa Gurgel, Elza Ferreira Noronha, Walter Massa Ramalho, Alex Leite Pereira, Svetoslav Nanev Slavov, Wildo Navegantes de Araújo, Rodrigo Haddad
- Enhancing testing and treatment uptake of HCV cascade care for the diabetes population via an integrated community-based shared care model
- Tsung-Hui Hu, Dih-Ling Luh, Yo-Yu Tsao, Li-Sheng Chen, Hsiu-Hsi Chen, Yen-Po Yeh
Bienvenue sur EM-consulte, la référence des professionnels de santé.